Cell Therapy/ Cell-based therapies

There is an alarming increase in the number of cases of diabetes with the global prevalence rate at 9% for the year 2014. Around 387 million patients worldwide are suffering from diabetes, and this number is expected to increase by 50% by 2030. In particular, the South East Asian countries are affected most due to diabetes with projected 10% increase in diabetic patients by 2035. Studies over the past several years highlight that cell-based therapies involving adult stem and progenitor cells hold promise of rescuing the dying endothelium in diabetes. This novel therapeutic strategy involves stem cells obtained from a variety of sources, such as circulating endothelial progenitor cells, mesenchymal stromal cells (MSCs), embryonic stem cells, and inducible pluripotent stem cells (iPSCs).Studies over the past several years highlight that cell-based therapies involving adult stem and progenitor cells hold promise of rescuing the dying endothelium in diabetes. This novel therapeutic strategy involves stem cells obtained from a variety of sources, such as circulating endothelial progenitor cells, mesenchymal stromal cells (MSCs), embryonic stem cells, and inducible pluripotent stem cells (iPSCs).

    Related Conference of Cell Therapy/ Cell-based therapies

    March 25-26, 2024

    5th Annual Conference on Diabetes

    London, UK
    July 11-12, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Cell Therapy/ Cell-based therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in